Disease / condition

Non-Alcoholic Fatty Liver Disease clinical trials

Free access to 120 studies·10+ countries·Updated daily50 recruiting
120
Total trials
10+
Countries
10+
Sponsors
50
Recruiting
By phase
N/A88
Phase 210
Phase 18
Phase 36
Phase 44
By status
Recruiting50
Completed26
Not yet recruit...18
Unknown16
Enrolling by in...4
Top countries
United States of America20
China8
Egypt7
Italy5
United Kingdom5
Top sponsors
Ain Shams Universi...3
Assiut University3
The University of ...3
Maastricht Univers...2
Altimmune, Inc.2
Recent trials
Latest clinical trials for Non-Alcoholic Fatty Liver Disease
SLCTR_2018_042·Early Phase 1Recruiting
The effect of a synbiotic (probiotic and prebiotic) supplementation on patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A proof of concept study
Durdans Hospital, 3, Alfred pl...Sri Lanka
SLCTR_2019_038·Phase 2
A non randomized controlled trial on the comparison of Delta-tocotrienol and Alpha-tocopherol Effects on Non-Alcoholic Fatty Liver Disease.
National University of Medical...Pakistan
NCT06355310·Phase 2Not yet recr...
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
Ann & Robert H Lurie Children'...
NCT06348628Recruitment ...
Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease
Madunil Anuk NiriellaSri Lanka
NCT06266559Not yet recr...
Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease
Chang Gung Memorial Hospital
NCT06140953·Phase 2Recruiting
Benefits of Trimetazidine in MAFLD Pateints
October 6 UniversityEgypt
NCT06133101·Phase 2Not yet recr...
Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
Marialena Mouzaki
NCT06095479Recruiting
Ultrasound Liver Fat Quantification on Pediatric Patients
Philips (China) Investment CO....China
NCT06097039Enrolling by...
Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease
Zagazig UniversityEgypt
NCT06152991·Phase 3Enrolling by...
Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
Yoon Jun KimSouth Korea
NCT06032650Not yet recr...
Calisthenics Versus High Intensity Interval Training in NAFL
Cairo University
NCT06026293Enrolling by...
Pharmacoeconomic Evaluation of the Cost/Effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease
Azienda Ospedaliera Specializz...Italy
NCT05987748Not yet recr...
The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD?
Leiden University Medical Cent...Netherlands
NCT05941910·Phase 2Recruiting
The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function
Attikon HospitalGreece
NCT05907408Not yet recr...
Omics Techniques in Fatty Liver Disease
Universidade Federal do Rio de...Brazil
NCT05897606·Phase 1Completed
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
Sulaimany Polytechnic universi...Iraq
NCT05885373Recruiting
A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLD
GenieBiome LimitedChina
NCT05866744Recruiting
Effects of Time-restricted Hypocaloric Diet in Patients With NAFLD
Agricultural University of Ath...Greece
NCT05810506Completed
Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements
Bandırma Onyedi Eylül Universi...Turkey
NCT05827432Not yet recr...
FCI Effectiveness in NAFLD Stratification
NHS Grampian
About this record

Access comprehensive clinical trial information for Non-Alcoholic Fatty Liver Disease through Pure Global AI's free database. This collection includes 120 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 50 trials are actively recruiting participants.

Research for Non-Alcoholic Fatty Liver Disease is being conducted in United States of America, China, Egypt and 7+ other countries. Leading sponsors include Ain Shams University and Assiut University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 120 clinical trials studying Non-Alcoholic Fatty Liver Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Ain Shams University, Assiut University, The University of Hong Kong, among others.